Semaglutide is currently priced at approximately $1,350 per month, while Zepbound is slightly less expensive at around $1,060 per month Given the data, Zepbound may exhibit a more potent effect on weight loss compared to semaglutide, particularly due to its dual-agonist nature targeting both GLP-1 and GIP receptors
Feeling bloated and uncomfortable is bad in general, but feeling off in your bathing suit is literally the worst
Daily oral orforglipron (Foundayo): Weekly injectable semaglutide for weight loss (Wegovy) : Average weight loss of 14.9 percent of body weight after about 15 months, compared with 2.4 percent in a placebo group Average weight loss of 21 percent of body weight after about 16 months, compared with 3.1 percent in a placebo group Weekly injectable tirzepatide for weight loss (Zepbound): Secondary Health Benefits Though this entire family of drugs has benefits for metabolic health, not every particular drug has been approved for the same conditions
L-Carnitine for an energy boost
Formulary placement Where Wegovy and Zepbound sit on your UHC formulary directly affects what you pay out of pocket
Chistol, L.T., et al
